Additionally, in patients with acute myeloid leukemia (AML), higher expression levels of STAB1 are significantly associated with leukocyte counts, lactate dehydrogenase levels, and poor clinical prognosis [66]. This evidence concerns the gene STAB1 and acute myeloid leukemia.